- Dynamic Antibody Response and Hybrid Immunity Following Multiple COVID-19 Vaccine Doses and Infection: A Case Study Cureus
- Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant The Lancet
- SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain | Communications Biology Nature.com
- How well do current vaccines hold up against new SARS-CoV-2 variants BA.2.86 and FLip? News-Medical.Net
- View Full coverage on Google News
